medPhoton GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
medPhoton GmbH - overview
Established
2001
Location
Salzburg, -, Austria
Primary Industry
Medical Devices & Equipment
About
Based in Austria, and founded in 2001, medPhoton GmbH operates as a medical technology company that develops medical equipment. The company is a spin-off of the radART institute of Paracelsus Medical University and the University Clinic for Radiotherapy and Radio-Oncology. In May 2022, Brainlab AG, a portfolio company of EMH Partners, acquired a majority stake in medPhoton GmbH. As of 2022, the company’s CEO is Heinz Deutschmann.
medPhoton manufactures various medical devices, including x-ray-based imaging equipment for surgery and radiation therapy applications. The company’s product line includes the medPhoton ImagingRing, which is a cone beam computed tomography (CBCT) medical imaging device that offers 3D imaging solutions, and open radART, which is radiation therapy medical software.
Current Investors
Brainlab AG
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment, Monitoring Equipment, Medical Software
Website
www.medphoton.at
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
medPhoton GmbH - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | medPhoton GmbH | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.